Literature DB >> 17955087

Peritoneal mesothelioma: a review.

Alessio Bridda1, Ilaria Padoan, Roberto Mencarelli, Mauro Frego.   

Abstract

BACKGROUND: Malignant peritoneal mesothelioma (MPM) is a rare aggressive tumor of the peritoneum, regarded as a universally fatal disease. It is poorly described and the knowledge of its natural history is very limited. Occupational and environmental asbestos exposure still remains a public health problem around the world. The incidence has increased in the past 2 decades. Only 20% to 33% of all mesotheliomas arise from the peritoneum itself; the pleura is the most common site of origin.

Entities:  

Mesh：

Year:  2007        PMID： 17955087      PMCID： PMC1994863     

Source DB:  PubMed          Journal:  MedGenMed        ISSN： 1531-0132


  73 in total

1.  [Diagnosis and treatment of 41 patients with malignant peritoneal mesothelioma].

Authors:  Zhong-guo Zhang; Xi-shan Hao
Journal:  Zhonghua Zhong Liu Za Zhi       Date:  2004-10

Review 2.  Advances in malignant mesothelioma.

Authors:  Bruce W S Robinson; Richard A Lake
Journal:  N Engl J Med       Date:  2005-10-13       Impact factor: 91.245

Review 3.  [Fever of unknown origin as the clinical presentation of malignant peritoneal mesothelioma].

Authors:  R Tejido García; M Anta Fernández; J L Hernández Hernández; J Bravo González; J González Macías
Journal:  An Med Interna       Date:  1997-11

4.  Phase I evaluation of humanized OKT3: toxicity and immunomodulatory effects of hOKT3gamma4.

Authors:  J Richards; J Auger; D Peace; D Gale; J Michel; A Koons; T Haverty; R Zivin; L Jolliffe; J A Bluestone
Journal:  Cancer Res       Date:  1999-05-01       Impact factor: 12.701

5.  Prognosis in malignant mesothelioma related to MIB 1 proliferation index and histological subtype.

Authors:  T W Beer; R Buchanan; A W Matthews; R Stradling; N Pullinger; R J Pethybridge
Journal:  Hum Pathol       Date:  1998-03       Impact factor: 3.466

Review 6.  [Peritoneal cystic mesothelioma. A clinical case and review of the literature].

Authors:  I Corsale; L Agozzino; C Nappo; C Corsale
Journal:  Minerva Chir       Date:  1999 Jul-Aug       Impact factor: 1.000

7.  [Peritoneal mesothelioma--incidence and etiology].

Authors:  V Neumann; K M Müller; M Fischer
Journal:  Pathologe       Date:  1999-05       Impact factor: 1.011

8.  [A case report of disseminated malignant mesothelioma of peritoneum responding remarkably to thalidomide, celecoxib, vinorelbine and CDDP].

Authors:  Masato Hada; Mizutari Kazuhiro
Journal:  Gan To Kagaku Ryoho       Date:  2004-12

9.  Successful immunochemotherapy for patients with malignant mesothelioma: report of two cases.

Authors:  M Tani; H Tanimura; H Yamaue; S Mizobata; M Yamamoto; M Iwahashi; K Ura; Y Nagai; T Tsunoda; H Wakasaki; K Nanjo; K Fujino; S Yukawa
Journal:  Surg Today       Date:  1998       Impact factor: 2.549

10.  [Malignant peritoneal mesothelioma occurring in periodic disease: apropos of a case].

Authors:  G Belange; H Gompel; Y Chaouat; D Chaouat
Journal:  Rev Med Interne       Date:  1998-06       Impact factor: 0.728
View more
  63 in total

Review 1.  Radical multimodality therapy for malignant pleural mesothelioma.

Authors:  Omar Abdel-Rahman; Zeinab Elsayed; Hadeer Mohamed; Mostafa Eltobgy
Journal:  Cochrane Database Syst Rev       Date:  2018-01-08

Review 2.  Malignant peritoneal mesothelioma: a review.

Authors:  Joseph Kim; Shanel Bhagwandin; Daniel M Labow
Journal:  Ann Transl Med       Date:  2017-06

Review 3.  Role of microRNAs in malignant mesothelioma.

Authors:  A Truini; S Coco; A Alama; C Genova; C Sini; M G Dal Bello; G Barletta; E Rijavec; G Burrafato; F Boccardo; F Grossi
Journal:  Cell Mol Life Sci       Date:  2014-02-23       Impact factor: 9.261

Review 4.  Case report: peritoneal mesothelioma from asbestos in hairdryers.

Authors:  James Dahlgren; Patrick Talbott
Journal:  Int J Occup Environ Health       Date:  2015

5.  A Phosphotyrosine Proteomic Screen Identifies Multiple Tyrosine Kinase Signaling Pathways Aberrantly Activated in Malignant Mesothelioma.

Authors:  Craig W Menges; Yibai Chen; Brooke T Mossman; Jonathan Chernoff; Anthony T Yeung; Joseph R Testa
Journal:  Genes Cancer       Date:  2010-05-01

6.  The assessment of the malignant mesothelioma cases and environmental asbestos exposure in Sivas province, Turkey.

Authors:  Serdar Berk; Huseyin Yalcin; Omer Tamer Dogan; Kursat Epozturk; Ibrahim Akkurt; Zehra Seyfikli
Journal:  Environ Geochem Health       Date:  2013-04-04       Impact factor: 4.609

Review 7.  Lung cancer: Biology and treatment options.

Authors:  Hassan Lemjabbar-Alaoui; Omer Ui Hassan; Yi-Wei Yang; Petra Buchanan
Journal:  Biochim Biophys Acta       Date:  2015-08-19

Review 8.  Surgical biology for the clinician: peritoneal mesothelioma: current understanding and management.

Authors:  Terence C Chua; Tristan D Yan; David L Morris
Journal:  Can J Surg       Date:  2009-02       Impact factor: 2.089

9.  The prognostic significance of BAP1, NF2, and CDKN2A in malignant peritoneal mesothelioma.

Authors:  Aatur D Singhi; Alyssa M Krasinskas; Haroon A Choudry; David L Bartlett; James F Pingpank; Herbert J Zeh; Alyssa Luvison; Kimberly Fuhrer; Nathan Bahary; Raja R Seethala; Sanja Dacic
Journal:  Mod Pathol       Date:  2015-10-23       Impact factor: 7.842

10.  Genome-wide profile of pleural mesothelioma versus parietal and visceral pleura: the emerging gene portrait of the mesothelioma phenotype.

Authors:  Oluf Dimitri Røe; Endre Anderssen; Eli Helge; Caroline Hild Pettersen; Karina Standahl Olsen; Helmut Sandeck; Rune Haaverstad; Steinar Lundgren; Erik Larsson
Journal:  PLoS One       Date:  2009-08-07       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.